Diagnostics
Total Trials
1
As Lead Sponsor
0
As Collaborator
NCT05016934
Evaluation of Safety and Immunogenicity of a Novel Vaccine for Prevention of Covid-19 in Adults Previously Immunized
Phase: Phase 1/2
Role: Collaborator
Start: Nov 1, 2021
Completion: Apr 20, 2022
Loading map...